LETTER
Paying for Kidney Donors
Aaron Spital
15 July 1993 | Volume 119 Issue 2 | Pages 172-173
TO THE EDITOR:
The recent important report by Sesso and colleagues [1] confirms that transplantation of kidneys from living, unrelated donors (LUDs) is at least as effective as transplantation from cadaveric donors. The authors' conclusion, however, that "payment for the donor or rewarded gifting is unacceptable" ignores a wealth of literature, which suggests that, under certain circumstances, financial incentives for living organ donation may indeed be reasonable.
Almost all agree that rampant commercialism, where the care of the donor is less important than the profit, is reprehensible [2]. Yet, some have suggested that rewarded gifting, wherein the donor is compensated under strict controls without middlemen, may be acceptable. Perhaps the most extensive published experience comes from Reddy and colleagues in Madras [3, 4]. In India, because the supply of dialysis facilities and kidneys from cadaveric donors are extremely limited, the diagnosis of end-stage renal disease is for many the equivalent of a death sentence. This situation led the group in Madras [3] to ask "Do we buy or let die?" They decided to embark on a program that accepted LUDs, using a system of rewarded gifting. Under their program of tightly regulated, paid donation, excellent medical care is provided for the donor in addition to 3 years of medical insurance. In more than 300 transplantations of kidneys from LUDs, they have achieved excellent results with no donor mortality and no decrease in the number of living, related donors [3, 4]. Other prominent transplant physicians have also concluded that rewarded gifting may be acceptable, at least in some parts of the world [2]. Even the Transplantation Society [5], which strongly opposes commercialization, agrees that "reimbursement for loss of work earnings and any other expenses related to the donation is acceptable."
As we encounter new and complex ethical problems in medicine, we must remain open-minded and be willing to explore creative new plans and ideas. Dogmatic statements that ignore the views and experience of others should be avoided.
1. Sesso R, Klag MJ, Ancao MS, Whelton PK, Seidler A, Sigulem D, et al. Kidney transplantation from living unrelated donors. Ann Intern Med. 1992; 117:983-9.
2. Daar AS, Sells RA. Living nonrelated donor renal transplantationa reappraisal. Transplantation Reviews. 1990; 4:128-40.
3. Reddy KC, Thiagarajan CM, Shunmugasundaram D, Jayachandran R, Nayar P, Thomas S, et al. Unconventional renal transplantation in India. Transplant Proc. 1990; 22:910-1.
4. Thiagarajan CM, Reddy KC, Shunmugasundaram D, Jayachandran R, Nayar P, Thomas S, et al. The practice of unconventional renal transplantation (UCRT) at a single centre in India. Transplant Proc. 1990; 22:912-4.
5. The Council of the Transplantation Society. Commercialization in transplantation: the problems and some guidelines for practice. Transplantation. 1986; 41:1-3.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.